On the second exhibition day of the Cte d'Azur Science and Technology Expo, the Middle East tyrant group led a delegation to see the goods today, and their arrival also attracted a lot of media attention and reports.

As soon as the local tyrant came, he was naturally treated as a guest by the sales department on the Côte d'Azur.

In the eyes of many people, these people wearing white robes and turbans are all "banknotes" that walk automatically, and these "banknotes" are now automatically walking into Luo Sheng's pocket.

Seeing this group of people enter the City of Galaxy, almost all of them are surprisingly envious of the Cote d'Azur, which is the rhythm of big business.

Sure enough, the local tyrants had just arrived in the morning, and the exact news came out in the afternoon that a business delegation sent by a number of Middle Eastern countries had signed a large contract with the Cote d'Azur company.

In the next three years, the company will provide these customers in the Middle East with graphene membrane filtration desalination system solutions, which will be delivered and put into use by 2021 at the latest.

The scale of demand of major local tyrants is different, and the amount of contract orders is also different.

The Criviera has the largest contract with Sater at $3.3 billion, followed by Qatar with $2.7 billion and the UAE at $2.2 billion.

There are relatively few other Middle Eastern tyrants, but the entire Middle East tyrant group smashed $11.5 billion in one go today.

Although it is impossible for the Côte d'Azur laboratory to recover the total investment cost of graphene materials by this order alone, this is only one of the application scenarios of graphene materials.

The most important thing is the continuous money-making effect, graphene membrane filter material is a consumable, and the technology belongs to the Cote d'Azur, which means that the local tyrants will run out in the future and will have to continue to purchase.

As long as the "money ability" of the local tyrant does not disappear, it can earn this money steadily, and how can the "money ability" of the local tyrant last for decades.

Earning for decades is not only enough, but the follow-up profits are also full of rhythm.

In fact, the contract list of more than $10 billion is an astronomical amount in itself, but it is a little less for the annual revenue of the Côte d'Azur.

But that's also a $11.5 billion list, which can definitely be called a super big order.

The outside world knows that the Côte d'Azur has been cultivated day after day for nearly 15 years, and today, fifteen years later, it has finally blossomed and borne fruit, and it is time for the harvest.

It is impossible not to envy that, but not to envy.

……

"The strong are always strong, the Cote d'Azur is so huge and the courage and foresight of the helmsman that the 'siphon effect' it has formed has almost extended its tentacles to the major boundaries of the field of science and technology, and the future ...... Perhaps it is only possible to survive by joining this system. ”

A middle-aged man in a suit and leather shoes looked around the expo and couldn't help but sigh with emotion, his name was Ding Xian, a manager of a venture capital institution.

There are too many people from investment institutions here at the expo site, and almost all of the technology companies participating in the exhibition are relatively potential start-ups, which are favored by venture capital institutions.

The reason is also very simple, these start-ups are basically companies that have been invested by Cote d'Azur or Shengfeng Capital, or subsidiaries and affiliated companies, which also means that these companies have been screened by Luo Sheng, the first person in the global technology industry today.

He is optimistic, and investors are of course more favored, which is equivalent to helping them pass a screening.

"Let's go over there."

Ding Xian said a word to the secretary assistant who followed him and walked towards the medical equipment exhibition area.

After a while, the two came to a very popular exhibition area, in addition to some science and technology enthusiasts, there are also many so-called elites in suits, they are basically either industry practitioners, or VC people, the exhibition area is a start-up company strategically invested by the Cote d'Azur - Hongrui Medical.

The founders are Zhao Yu and Lu Zhengyang, both of whom are young doctors in their thirties, both of whom graduated from Rice University in North America, and belonged to the same laboratory during their time in school, and later decided to return to China to start a business.

Originally, they didn't want to return to China to start a business, and the environment abroad was better, but in the end, one of the biggest factors that prompted them to return to China to start a business was that there was a science and technology giant named Luo Sheng in China, a technology company called the Cote d'Azur, and an investment institution called Shengfeng Capital.

Compared with other institutions or entrepreneurial environments, Luo Sheng and his institutions are really constantly investing in the field of science and technology, rather than making money, and are really constantly throwing money.

This gave the two of them great confidence, in fact, the Cote d'Azur and Shengfeng Capital did not let their expectations be disappointed, Zhao Yu personally found the people of Shengfeng Capital, and as a result, halfway through his story, he got an angel round investment of 4 million yuan on the same day.

Last year, Zhao Yu and Lu Zhengyang published their latest nanomedicine research results in the journal Nature under the name of Hongrui Medical, which they co-founded.

That is, the nanobot that they announced at the expo today that can kill cancer cells.

At this moment, Ding Xian stood in the crowd and silently watched Lu Zhengyang, who came here to promote his own products, introduce their achievements.

"The nanobot developed by our company, which is only 1/50,000 the diameter of a human hair, can be driven by light and rotate at a high speed of 3 million times per second into designated cancer cells that have been labeled in advance, so as to turn over the inside of the cancer cells. It only takes one to three minutes to physically and completely kill cancer cells. ”

Lu Zhengyang's introduction undoubtedly caused the surprise of many people present, and most of them showed surprised expressions when they heard him say this.

Of course, the so-called nanorobots are invisible to the naked eye, and Lu Zhengyang also shows them in his own exhibition area by playing videos in the laboratory and some microscopic display pictures.

An industry insider at the scene couldn't help but say: "If it's really like you said, even cancer cells that already have super drug resistance can't withstand this kind of toss, then what is the core of this nanorobot?" ”

In the face of inquiries from industry insiders, Lu Zhengyang smiled and happily explained: "The driving core structure that acts as the 'engine' of this nanorobot is a rotor-like 'atomic chain' that we call a 'triple chain'. It is made of nano-sized particles and can move freely on uneven atomic surfaces, relying on the 'driving shaft' of the 'triple chain'. ”

The non-professional passers-by present who ate melons could only have an unclear feeling.

Hongrui Medical was founded in early 2015, when the concept of micromolecular machines had not yet been popularized, and it was not until 2016 that someone in this field won the Nobel Prize, and then it began to be popularized.

Zhao Yu and Lu Zhengyang had already come up with the idea of using the principle of molecular machines to develop nanorobots in 2014, and it was precisely because of this opportunity that the two of them got acquainted with each other, and their like-minded careers made them decide to start a business together, hoping to use their professional knowledge and skills to achieve something in the field of micromolecular machines.

This is the birth of Hongrui Medical.